Angiotensin II receptor blocker: Candesartan cilexetil

被引:0
|
作者
Inada, Y [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Res Management Dept, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:35P / 35P
页数:1
相关论文
共 50 条
  • [1] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [2] Candesartan cilexetil: An angiotensin II-receptor blocker
    See, S
    Stirling, AL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (08) : 739 - 746
  • [3] Angiotensin II receptor antagonists: Candesartan cilexetil
    Naka, T
    Kubo, K
    Nishikawa, K
    Inada, Y
    Furukawa, Y
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1261 - 1275
  • [4] Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy
    Shirai, K
    Watanabe, K
    Ma, ML
    Wahed, MII
    Inoue, M
    Saito, Y
    Suresh, PS
    Kashimura, T
    Tachikawa, H
    Kodama, M
    Aizawa, Y
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 269 (1-2) : 137 - 142
  • [5] Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy
    Ken Shirai
    Kenichi Watanabe
    Meilei Ma
    Mir I I Wahed
    Mikio Inoue
    Yuki Saito
    Palaniyandi Selvaraj Suresh
    Takeshi Kashimura
    Hitoshi Tachikawa
    Makoto Kodama
    Yoshifusa Aizawa
    [J]. Molecular and Cellular Biochemistry, 2005, 269 : 137 - 142
  • [7] The angiotensin II receptor blocker (ARB) candesartan cilexetil decreases portal vascular resistance in liver cirrhosis
    Ito, M
    Hachiya, A
    Nakano, S
    Hanzawa, M
    Katagiri, M
    Kurita, T
    Matsuzaki, H
    Igarashi, Y
    Iida, K
    Miki, K
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A663 - A663
  • [8] Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil
    Sever, PS
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 : S9 - S12
  • [9] Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis, B.
    Page, S. R.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1995 - 2007
  • [10] Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease
    Yoshifuru Tamura
    Masahiro Kosuga
    Masahiro Yamashita
    Satoru Tomioka
    Michiko Sasaki
    Tomoyuki Hikita
    Hideaki Nakajima
    Kenichiro Kojima
    Shunya Uchida
    [J]. Clinical and Experimental Nephrology, 2008, 12 : 256 - 263